Home A systematic review and meta-analysis of the preclinical and clinical results of low-field magnetic stimulation in cognitive disorders
Article
Licensed
Unlicensed Requires Authentication

A systematic review and meta-analysis of the preclinical and clinical results of low-field magnetic stimulation in cognitive disorders

  • Nicholas Mellon ORCID logo EMAIL logo , Brett Robbins ORCID logo , Rebekah van Bruggen and Yanbo Zhang
Published/Copyright: April 29, 2024
Become an author with De Gruyter Brill

Abstract

Cognitive disorders such as major depressive disorder and bipolar disorder severely compromise brain function and neuronal activity. Treatments to restore cognitive abilities can have severe side effects due to their intense and excitatory nature, in addition to the fact that they are expensive and invasive. Low-field magnetic stimulation (LFMS) is a novel non-invasive proposed treatment for cognitive disorders. It repairs issues in the brain by altering deep cortical areas with treatments of low-intensity magnetic stimulation. This paper aims to summarize the current literature on the effects and results of LFMS in cognitive disorders. We developed a search strategy to identify relevant studies utilizing LFMS and systematically searched eight scientific databases. Our review suggests that LFMS could be a viable and effective treatment for multiple cognitive disorders, especially major depressive disorder. Additionally, longer, more frequent, and more personalized LFMS treatments tend to be more efficacious.


Corresponding author: Nicholas Mellon, Faculty of Medicine and Dentistry, The University of Alberta, Edmonton, AB, T6G 2E1, Canada, E-mail:

Award Identifier / Grant number: USRA

  1. Research ethics: Not applicable.

  2. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: The authors state no conflict of interest.

  4. Research funding: Natural Science and Engineering Research Council of Canada Undergraduate Student Research Award (NSERC USRA).

  5. Data availability: Not applicable.

References

Al-Harbi, K.S. (2012). Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer. Adherence 6: 369–388, https://doi.org/10.2147/ppa.s29716.Search in Google Scholar

Arzy, S. and Danziger, S. (2014). The science of neuropsychiatry: past, present, and future. J. Neuropsychiatry Clin. Neurosci. 26: 392–395, https://doi.org/10.1176/appi.neuropsych.13120371.Search in Google Scholar PubMed

Bray, N.J. and O’Donovan, M.C. (2019). The genetics of neuropsychiatric disorders. Brain Neurosci. Adv. 2: 1, https://doi.org/10.1177/2398212818799271.Search in Google Scholar PubMed PubMed Central

Carlezon, W.A.Jr., Rohan, M.L., Mague, S.D., Meloni, E.G., Parsegian, A., Cayetano, K., Tomasiewicz, H.C., Rouse, E.D., Cohen, B.M., and Renshaw, P.F. (2005). Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats. Biol. Psychiatr. 57: 571–576, https://doi.org/10.1016/j.biopsych.2004.12.011.Search in Google Scholar PubMed

Christiansen, M.G., Senko, A.W., and Anikeeva, P. (2019). Magnetic strategies for nervous system control. Annu. Rev. Neurosci. 42: 271–293, https://doi.org/10.1146/annurev-neuro-070918-050241.Search in Google Scholar PubMed PubMed Central

Dolgova, N., Wei, Z., Spink, B., Gui, L., Hua, Q., Truong, D., Zhang, Z., and Zhang, Y. (2021). Low-field magnetic stimulation accelerates the differentiation of oligodendrocyte precursor cells via non-canonical TGF-beta signaling pathways. Mol. Neurobiol. 58: 855–866, https://doi.org/10.1007/s12035-020-02157-0.Search in Google Scholar PubMed

Dubin, M.J., Ilieva, I.P., Deng, Z.D., Thomas, J., Cochran, A., Kravets, K., Brody, B.D., Christos, P.J., Kocsis, J.H., Liston, C., et al.. (2019). A double-blind pilot dosing study of low field magnetic stimulation (LFMS) for treatment-resistant depression (TRD). J. Affect. Disord. 249: 286–293, https://doi.org/10.1016/j.jad.2019.02.039.Search in Google Scholar PubMed PubMed Central

Fava, M., Freeman, M.P., Flynn, M., Hoeppner, B.B., Shelton, R., Iosifescu, D.V., Murrough, J.W., Mischoulon, D., Cusin, C., Rapaport, M., et al.. (2018). Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD). Brain Stimul. 11: 75–84, https://doi.org/10.1016/j.brs.2017.09.010.Search in Google Scholar PubMed PubMed Central

Higgins, J.P.T., Altman, D.G., Gøtzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., Savovic, J., Schulz, K.F., Weeks, L., Sterne, J.A., et al.. (2011). The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343: d5928, https://doi.org/10.1136/bmj.d5928.Search in Google Scholar PubMed PubMed Central

Hooijmans, C.R., Rovers, M.M., de Vries, R.B., Leenaars, M., Ritskes-Hoitinga, M., and Langendam, M.W. (2014). SYRCLE’s risk of bias tool for animal studies. BMC Med. Res. Methodol. 14: 43, https://doi.org/10.1186/1471-2288-14-43.Search in Google Scholar PubMed PubMed Central

Howes, O.D., Thase, M.E., and Pillinger, T. (2021). Treatment resistance in psychiatry: state of the art and new directions. Mol. Psychiatr. 27: 69, https://doi.org/10.1038/s41380-021-01200-3.Search in Google Scholar PubMed PubMed Central

Leuchter, A.F., Cook, I.A., Feifel, D., Goethe, J.W., Husain, M., Carpenter, L.L., Thase, M.E., Krystal, A.D., Philip, N.S., Bhati, M.T., et al.. (2015). Efficacy and safety of low-field synchronized transcranial magnetic stimulation (sTMS) for treatment of major depression. Brain Stimul. 8: 787–794, https://doi.org/10.1016/j.brs.2015.05.005.Search in Google Scholar PubMed

Leuchter, A.F., Cook, I.A., Jin, Y., and Phillips, B. (2013). The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Front. Hum. Neurosci. 7: 37, https://doi.org/10.3389/fnhum.2013.00037.Search in Google Scholar PubMed PubMed Central

Mclean, Hospital. (2017). Multiple treatment study using low field magnetic stimulation for bipolar depression. Available at: <https://ClinicalTrials.gov/show/NCT0192968>.Search in Google Scholar

Rohan, M., Parow, A., Stoll, A.L., Demopulos, C., Friedman, S., Dager, S., Hennen, J., Cohen, B.M., and Renshaw, P.F. (2004). Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator. Am. J. Psychiatr. 161: 93–98, https://doi.org/10.1176/appi.ajp.161.1.93.Search in Google Scholar PubMed

Rohan, M.L., Yamamoto, R.T., Ravichandran, C.T., Cayetano, K.R., Morales, O.G., Olson, D.P., Vitaliano, G., Paul, S.M., and Cohen, B.M. (2014). Rapid mood-elevating effects of low field magnetic stimulation in depression. Biol. Psychiatr. 76: 186–193, https://doi.org/10.1016/j.biopsych.2013.10.024.Search in Google Scholar PubMed

Rooney, A.A., Boyles, A.L., Wolfe, M.S., Bucher, J.R., and Thayer, K.A. (2014). Systematic review and evidence integration for literature-based environmental health science assessments. Environ. Health Perspect. 122: 711–718, https://doi.org/10.1289/ehp.1307972.Search in Google Scholar PubMed PubMed Central

Sekar, S., Zhang, Y., Miranzadeh Mahabadi, H., Parvizi, A., and Taghibiglou, C. (2019). Low-field magnetic stimulation restores cognitive and motor functions in the mouse model of repeated traumatic brain injury: role of cellular prion protein. J. Neurotrauma 36: 3103–3114, https://doi.org/10.1089/neu.2018.5918.Search in Google Scholar PubMed

Shafi, M., Stern, A.P., and Pascual-Leone, A. (2014). Adding low-field magnetic stimulation to noninvasive electromagnetic neuromodulatory therapies. Biol. Psychiatr. 76: 170–171, https://doi.org/10.1016/j.biopsych.2014.05.017.Search in Google Scholar PubMed PubMed Central

Silva, S., Basser, P.J., and Miranda, P.C. (2008). Elucidating the mechanisms and loci of neuronal excitation by transcranial magnetic stimulation using a finite element model of a cortical sulcus. Clin. Neurophysiol. 119: 2405–2413, https://doi.org/10.1016/j.clinph.2008.07.248.Search in Google Scholar PubMed PubMed Central

Sun, Z., Jiang, T., Wu, Y., Ma, C., He, Y., and Yang, J. (2018). Low field magnetic stimulation ameliorates schizophrenia-like behavior and up-regulates neuregulin-1 expression in a mouse model of cuprizone-induced demyelination. Front. Psychiatr. 9: 675, https://doi.org/10.3389/fpsyt.2018.00675.Search in Google Scholar PubMed PubMed Central

Tal Medical Group, Inc. (2017). Low field magnetic stimulation (LFMS) in subjects with treatment-resistant depression (TRD). Available at: <https://ClinicalTrials.gov/show/NCT02452892>.Search in Google Scholar

Voineskos, D., Daskalakis, Z.J., and Blumberger, D.M. (2020). Management of treatment-resistant depression: challenges and strategies. Neuropsychiatr. Dis. Treat. 16: 221–234, https://doi.org/10.2147/ndt.s198774.Search in Google Scholar PubMed PubMed Central

Volkow, N.D., Tomasi, D., Wang, G.J., Fowler, J.S., Telang, F., Wang, R., Alexoff, D., Logan, J., Wong, C., Pradhan, K., et al.. (2010). Effects of low-field magnetic stimulation on brain glucose metabolism. Neuroimage 51: 623–628, https://doi.org/10.1016/j.neuroimage.2010.02.015.Search in Google Scholar PubMed PubMed Central

Wang, Z., Baharani, A., Wei, Z., Truong, D., Bi, X., Wang, F., Li, X., Verge, V.M., and Zhang, Y. (2021). Low field magnetic stimulation promotes myelin repair and cognitive recovery in chronic cuprizone mouse model. Clin. Exp. Pharmacol. Physiol. 48: 1090–1102, https://doi.org/10.1111/1440-1681.13490.Search in Google Scholar PubMed

Xiao, L., Correll, C.U., Feng, L., Xiang, Y.T., Feng, Y., Hu, C., Li, R., and Wang, G. (2019). Rhythmic low-field magnetic stimulation may improve depression by increasing brain-derived neurotrophic factor. CNS Spectr. 24: 313–321, https://doi.org/10.1017/s1092852917000670.Search in Google Scholar PubMed

Zhen, J., Qian, Y., Weng, X., Su, W., Zhang, J., Cai, L., Dong, L., An, H., Su, R., Wang, J., et al.. (2017). Gamma rhythm low field magnetic stimulation alleviates neuropathologic changes and rescues memory and cognitive impairments in a mouse model of Alzheimer’s disease. Alzheim. Dement. 3: 487–497, https://doi.org/10.1016/j.trci.2017.07.002.Search in Google Scholar PubMed PubMed Central


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/revneuro-2024-0023).


Received: 2024-02-01
Accepted: 2024-03-18
Published Online: 2024-04-29
Published in Print: 2024-08-27

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 6.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/revneuro-2024-0023/html
Scroll to top button